Atossa Therapeutics Inc (NASDAQ:ATOS) announced that its board of directors has approved a share repurchase program with authorization to purchase up to $10 million of Atossa common stock through December 31, 2023.
The clinical-stage biopharmaceutical firm said under the program, shares will be repurchased from time to time in open market transactions, privately negotiated block transactions, or by other means.
Graphene Manufacturing Group Ltd (TSX-V:GMG, OTC:GMGMF) announced that Bob Galyen, a member of the company’s technical advisory committee, will join its board of directors.
Gaylen has been on the committee since June 2022. He joins the board of directors effective July 1.
American Resources Corporation (NASDAQ:AREC) revealed that the initial shipment of lithium ore feedstock has been funded and shipped as part of an overall offtake partnership with its South African business collaborators.
The Fishers, Indiana-based supplier of raw materials to the global infrastructure market, said it has started the shipment of lithium spodumene ores from Africa which will be refined to greater than 99.9% battery-grade lithium carbonate or hydroxide using its patented ReElement Technologies refining process.
ARway.ai (CSE:ARWY, OTCQB:ARWYF) has revealed a surge in its sales pipeline, which has soared by over 70% in just six weeks, reaching $2.5 million in potential enterprise contracts.
ARway.ai said this significant growth presents a substantial revenue opportunity for the company as it expands its presence in the global indoor navigation industry.
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has said it is considering the potential spin-off of its NP-120 (Ifenprodil) chronic cough research program.
The company said it has engaged Maxim Group LLC to provide financial advisory and investment banking services with a focus on identifying and evaluating potential mergers and acquisitions (M&A) and strategic opportunities including the potential spin-off.
Solis Minerals Ltd (ASX:SLM, TSX-V:SLMN, OTCQB:SLMFF) and Lind Partners have mutually agreed not to enter a A$2 million funding agreement after Solis secured strong support for both its A$8 million placement and the exercise of unquoted options.
Earlier this month, Solis received firm commitments to raise A$8.155 million through a placement of shares to sophisticated and professional investors as well as North American institutional funds.
Lion Copper and Gold Corp has announced that at its annual general and special meeting of shareholders held on June 20, 2023, all resolutions were passed.
QC Copper and Gold Inc said it has completed all obligations under its option agreement to acquire a 100% interest in the Opemiska Project. "This achievement marks a significant milestone for QC Copper's journey, and we express our gratitude to the vendors, Ex-In and the Gaucher family, for their partnership in the development of Opemiska, with the common goal of establishing the next copper and gold open pit mine in Canada," said Stephen Stewart, QC Copper and Gold CEO. As per its announcement on December 12, 2018, QC Copper and Explorateurs-Innovateurs de Quebec Inc, a private arms-length company, entered into a definitive agreement to provide the Ccmpany with a 100% interest in the Opemiska Project.
Wishpond Technologies Ltd said the TSX Venture Exchange has accepted a notice filed by the company of its intention to make a normal course issuer bid. The company said its board of directors believes that the recent market prices of its common shares do not properly reflect the underlying value of such Shares. As a result, depending upon future price movements and other factors, the board believes that the purchase of the shares would be a desirable use of corporate funds in the best interests of the company and its shareholders. The normal course issuer bid notice provides that the company may, during the 12-month period commencing June 30, 2023, and ending June 29, 2024, purchase up to 2,688,431 shares in total, being 5% of the total number of 53,768,620 shares outstanding as at June 12, 2023. The price which the company will pay for any such shares will be the prevailing market price at the time of acquisition. All share purchases will be made on the open market through the facilities of the Exchange and will be purchased for cancellation. The funding for any purchase under the normal course issuer bid will be financed out of the working capital of the company.
Cardiol Therapeutics Inc has announced that its virtual Annual General Meeting (AGM) of shareholders will be webcast on June 28, 2023, at 4.30pm EDT via the following live audio webcast link: web.lumiagm.com/419302032. Additional information on the AGM, including details on how to participate and vote, is available on the company's website at cardiolrx.com/investors/events-presentations/.
Nextech3D.ai has issued a shareholder update highlighting that it is perfectly positioned to capitalize on the transformational technology shift that is happening now with Artificial Intelligence (AI), Three Dimensional (3D) models, Augmented Reality (AR) and Machine Learning (ML). The full update can be read on the Nextech3D.ai corporate website at: https://www.nextechar.com/press-releases-and-media
Black Swan Graphene Inc said it is to present the marketing material prepared by Nationwide Engineering Research and Development (NERD), featuring Black Swan and showcasing the ongoing collaboration between Black Swan, NERD, ARUP, and other prominent entities. Simon Marcotte, president, and chief executive officer of Black Swan, commented: "As the world continues its transition towards reducing CO2 emissions, substantial investments have been directed towards the transportation industry, facilitating the development of battery manufacturing, as well as a transformation of energy generation and transmission. Government-established standards have been the driving force behind this phenomenon. It is only a matter of time before similar standards are set for the concrete industry, which alone accounts for 8% of CO2 emissions. The recent announcement by the City of Toronto is a clear indication of this potential." To access the document, interested parties can visit NERD's website at: https://www.concretene.co.uk/prospectus/
BioHarvest Sciences Chief Medical Officer, Brian Cornblatt will deliver the keynote speech at the "HealthConf" stage at the Collision technology conference June 29th at 10:45 am ET. Cornblatt will also lead a roundtable discussion on Wednesday, June 28, at 11:00 AM ET, centered around how technology can help enhance sustainability in production, especially in regards to plants and medicines. "I am looking forward to the opportunity to bring BioHarvest to such a large international stage with an audience of people looking to make a difference in technology," said Dr. Cornblatt. "For the first time, I will be publicly sharing the personal journey that brought me to believe in nutraceuticals and ultimately in BioHarvest's botanical synthesis technology, which I believe is about to disrupt the nutraceutical industry."